1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Bio-Rad Laboratories Inc.
- Expedeon AG
- Fluidigm Corp.
- JN Medsys
- Merck KGaA
- QIAGEN NV
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Digital PCR (dPCR) Market 2020-2024
The author has been monitoring the global digital PCR (dPCR) market and it is poised to grow by USD 252.26 mn during 2020-2024, progressing at a CAGR of 11% during the forecast period. The reports on global digital PCR (dPCR) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing use of dPCR in pathogen detection and disease diagnosis. In addition, growing applications of beaming technology-based dPCR workflows is anticipated to boost the growth of the global digital PCR (dPCR) market as well.
Market Segmentation
The global digital PCR (dPCR) market is segmented as below:
Product
Geographic segmentation
Key Trends for global digital PCR (dPCR) market growth
This study identifies growing applications of beaming technology-based dPCR workflows as the prime reasons driving the global digital PCR (dPCR) market growth during the next few years.
Prominent vendors in global digital PCR (dPCR) market
We provide a detailed analysis of around 25 vendors operating in the global digital PCR (dPCR) market, including some of the vendors such as Bio-Rad Laboratories Inc., Expedeon AG, Fluidigm Corp., JN Medsys, Merck KGaA, QIAGEN NV, Stilla Technologies, Sysmex Corp. and Thermo Fisher Scientific Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The author has been monitoring the global digital PCR (dPCR) market and it is poised to grow by USD 252.26 mn during 2020-2024, progressing at a CAGR of 11% during the forecast period. The reports on global digital PCR (dPCR) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing use of dPCR in pathogen detection and disease diagnosis. In addition, growing applications of beaming technology-based dPCR workflows is anticipated to boost the growth of the global digital PCR (dPCR) market as well.
Market Segmentation
The global digital PCR (dPCR) market is segmented as below:
Product
- Consumables
- Instruments
Geographic segmentation
- North America
- Europe
- Asia
- ROW
Key Trends for global digital PCR (dPCR) market growth
This study identifies growing applications of beaming technology-based dPCR workflows as the prime reasons driving the global digital PCR (dPCR) market growth during the next few years.
Prominent vendors in global digital PCR (dPCR) market
We provide a detailed analysis of around 25 vendors operating in the global digital PCR (dPCR) market, including some of the vendors such as Bio-Rad Laboratories Inc., Expedeon AG, Fluidigm Corp., JN Medsys, Merck KGaA, QIAGEN NV, Stilla Technologies, Sysmex Corp. and Thermo Fisher Scientific Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Bio-Rad Laboratories Inc.
- Expedeon AG
- Fluidigm Corp.
- JN Medsys
- Merck KGaA
- QIAGEN NV
01: EXECUTIVE SUMMARY07: CUSTOMER LANDSCAPE09: DECISION FRAMEWORK
02: SCOPE OF THE REPORT
03: MARKET LANDSCAPE
04: MARKET SIZING
05: FIVE FORCES ANALYSIS
06: MARKET SEGMENTATION BY PRODUCT
08: GEOGRAPHIC LANDSCAPE
10: DRIVERS AND CHALLENGES
11: MARKET TRENDS
12: VENDOR LANDSCAPE
13: VENDOR ANALYSIS
14: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Bio-Rad Laboratories Inc.
- Expedeon AG
- Fluidigm Corp.
- JN Medsys
- Merck KGaA
- QIAGEN NV
The following companies as the key players in the global digital PCR (dPCR) market: Bio-Rad Laboratories Inc., Expedeon AG, Fluidigm Corp., JN Medsys, Merck KGaA, QIAGEN NV, Stilla Technologies, Sysmex Corp. and Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is growing applications of beaming technology-based dPCR workflows”
According to the report, one of the major drivers for this market is the increasing use of dPCR in pathogen detection and disease diagnosis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is growing applications of beaming technology-based dPCR workflows”
According to the report, one of the major drivers for this market is the increasing use of dPCR in pathogen detection and disease diagnosis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Bio-Rad Laboratories Inc.
- Expedeon AG
- Fluidigm Corp.
- JN Medsys
- Merck KGaA
- QIAGEN NV
- Stilla Technologies
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
